Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Tammam Hanna

Orthopaedic Surgery Jackson, MS Medical Doctor

NPI 1306464169 CMS profile 9994794

2500 North State Street, Jackson, MS 39216

Open in the dashboard

General payments

$47,155

195 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Tammam Hanna of Jackson, MS is reported in the CMS Open Payments database as having received $47,155 across 195 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,921 18
2024 General $6,844 52
2023 General $16,727 43
2022 General $11,868 40
2021 General $8,795 42

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tammam Hanna
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Tammam Hanna were reported at $2,921. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Tammam Hanna Orthopaedic Surgery median Middle half National median
2019 $0 $644 $140–$2,844 $163
2020 $0 $312 $75–$1,860 $114
2021 $8,795 $520 $117–$2,495 $132
2022 $11,868 $598 $128–$2,731 $149
2023 $16,727 $461 $128–$2,264 $160
2024 $6,844 $497 $134–$2,475 $164
2025 $2,921 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Arthrex, Inc. $21,858 73 payments
  2. Stryker Corporation $3,220 26 payments
  3. TriMed, Inc. $2,858 14 payments
  4. FX Shoulder USA, Inc $2,823 2 payments
  5. Anika Therapeutics, Inc. $2,470 7 payments
  6. Medical Device Business Services, Inc. $2,152 16 payments
  7. ETS Wound Care LLC $1,940 7 payments
  8. Rattan and Associates $1,823 5 payments
  9. Lima USA, Inc. $1,802 7 payments
  10. AxoGen $1,378 4 payments
  11. Other $4,832 34 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Travel and Lodging $18,902 50 payments
  2. Grant $10,000 1 payment
  3. Education $9,228 12 payments
  4. Food and Beverage $9,024 132 payments
Products named General payments · program years 2021–2025
  1. Tools - WFS $2,858 14 payments
  2. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $2,064 14 payments
  3. MIRRAGEN ADVANCED WOUND MATRIX $1,940 7 payments
  4. WristMotion $1,666 4 payments
  5. Avance Nerve Graft $1,378 4 payments
  6. EQUINOXE $1,374 3 payments
  7. SMR Shoulder $1,184 5 payments
  8. DYNACORD $938 11 payments
  9. OVOMotion $782 2 payments
  10. X-Twist $722 1 payment
  11. Other $4,840 56 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

154

Median for Hand Surgery: 118

Drug cost

$1,937

Median for Hand Surgery: $615

Branded share of claims

18.2%

Median for Hand Surgery: 34.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 20 $922
Gabapentin Generic 60 $492
Cephalexin Generic 19 $223
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 14 $124
Acetaminophen-Codeine Acetaminophen With Codeine Brand 14 $96
Tramadol Hcl Generic 27 $80

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,399 Part D prescribers listed as Hand Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 92 billing codes

Paid by Medicare

$87,435

Of which drugs: $30

Medicare patients

181

Average age 72

Services billed

973

110 women, 71 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 64%
Diabetes 36%
Ischemic heart disease 33%
Depression 28%
Atrial fibrillation 20%
Chronic kidney disease 19%
Osteoporosis 19%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 42 332 $30

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

195 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Mississippi

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record